199 related articles for article (PubMed ID: 30262775)
41. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
42. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
Tseng CH
Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
[TBL] [Abstract][Full Text] [Related]
43. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
44. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
Tseng CH
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1389-1400. PubMed ID: 36939574
[TBL] [Abstract][Full Text] [Related]
45. Effects of pioglitazone on the incidence of dementia in patients with diabetes.
Chou PS; Ho BL; Yang YH
J Diabetes Complications; 2017 Jun; 31(6):1053-1057. PubMed ID: 28254448
[TBL] [Abstract][Full Text] [Related]
46. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
[TBL] [Abstract][Full Text] [Related]
47. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
J Am Acad Dermatol; 2018 Apr; 78(4):694-700. PubMed ID: 29246826
[TBL] [Abstract][Full Text] [Related]
48. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
[TBL] [Abstract][Full Text] [Related]
49. Human Insulin Therapy Is Associated With an Increased Risk of Lung Cancer: A Population-Based Retrospective Cohort Study.
Tseng CH
Front Endocrinol (Lausanne); 2019; 10():443. PubMed ID: 31354621
[No Abstract] [Full Text] [Related]
50. Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Eur J Endocrinol; 2021 Feb; 184(2):299-310. PubMed ID: 33270043
[TBL] [Abstract][Full Text] [Related]
51. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
[TBL] [Abstract][Full Text] [Related]
52. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
[TBL] [Abstract][Full Text] [Related]
53. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract][Full Text] [Related]
54. Sitagliptin and oral cancer risk in type 2 diabetes patients.
Tseng CH
Oncotarget; 2017 Nov; 8(57):96753-96760. PubMed ID: 29228568
[TBL] [Abstract][Full Text] [Related]
55. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
[TBL] [Abstract][Full Text] [Related]
56. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
57. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
[TBL] [Abstract][Full Text] [Related]
58. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
Tseng CH
Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
[TBL] [Abstract][Full Text] [Related]
59. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443
[TBL] [Abstract][Full Text] [Related]
60. Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
Tseng CH
Clin Breast Cancer; 2017 Jun; 17(3):211-218. PubMed ID: 27986440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]